wtR6IP

General Information


DRACP ID  DRACP05953

Peptide Name   wtR6IP

Sequence  DDEKEQFLYHLLSFNAV

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Cell-penetrating peptides Rab8a GTPase inhibitor



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Rab8a GTPase

Affinity  rel.Kd=8.7 (rel.Kd=[Kd(peptide)/ Kd(StRIP3)])*

*  Cmax[Rab8a6-176(GppNHp)]=300 µM, Kd(StRIP3)=17.5 µM

Mechanism  Binds Rab8a(GppNHp) and is able to inhibit a Rab8a PPI.

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Fluorescein-O2OC-

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C95H138N22O30

Absent amino acids  CGIMPRTW

Common amino acids  L

Mass  235385

Pl  4.1

Basic residues  2

Acidic residues  4

Hydrophobic residues  7

Net charge  -2

Boman Index  -3042

Hydrophobicity  -42.35

Aliphatic Index  91.76

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  93.13

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 27336832

Title  Protease-Resistant and Cell-Permeable Double-Stapled Peptides Targeting the Rab8a GTPase

Doi 2016

Year 

Patent

Patent ID 

Patent Title 

Other Iinformation 

Other Published ID   




DRACP is developed by Dr.Zheng's team.